Positron-Emitting N-[18F]Fluoroalkyl and [18F]Fluoropyrrolidinyl Analogues of Eticlopride as Potential in Vivo Radioligands for Dopamine D2 Receptors

Minoru Maeda, Shigeki Sasaki, Etsuko Fukuzawa, Kiyoko Watanabe, K. Kojima, Toshimitsu Fukumura, Takashi Tahara, Kouji Masuda, Yuichi Ichiya

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

N-Fluoroalkyl and 4-fluoropyrrolidinyl eticlopride analogues with high affinity toward central nervous system dopamine D2 receptors in vitro were labelled with positron emitting fluorine-18 (fl/2 = 110 min), and their in vivo biodistribution was investigated in rats. 7V-[18F]Fluoro-ethyl and -propyl eticlopride derivatives showed poor in vivo selectivity in the rat brain. On the other hand, 4-[18F]fluoropyrrolidinyl eticlopride exhibited almost constant and relatively high striatal concentration. The striatal/cerebellar radioactivity ratio, which corresponds to the ratio of a brain D2 receptor-rich to poor region, gradually increased to 5.2—6.4, 90 min after the injection. The striatal accumulation was selectively inhibited by pre-injection of haloperidol, a dopamine D2 antagonist, without affecting accumulation in other tissues. Thus, the selective striatal accumulation of 4-[18F]fluoropyrrolidinyl eticlopride in striatal tissue appears to be due to the specific binding to dopamine D2 receptors.

Original languageEnglish
Pages (from-to)1793-1798
Number of pages6
JournalChemical and Pharmaceutical Bulletin
Volume40
Issue number7
DOIs
Publication statusPublished - Jan 1 1992

Fingerprint

eticlopride
Corpus Striatum
Dopamine D2 Receptors
Positrons
Electrons
Rats
Brain
Tissue
Fluorine
Radioactivity
Neurology
Haloperidol
Injections
Derivatives
Central Nervous System

All Science Journal Classification (ASJC) codes

  • Chemistry(all)
  • Drug Discovery

Cite this

Positron-Emitting N-[18F]Fluoroalkyl and [18F]Fluoropyrrolidinyl Analogues of Eticlopride as Potential in Vivo Radioligands for Dopamine D2 Receptors. / Maeda, Minoru; Sasaki, Shigeki; Fukuzawa, Etsuko; Watanabe, Kiyoko; Kojima, K.; Fukumura, Toshimitsu; Tahara, Takashi; Masuda, Kouji; Ichiya, Yuichi.

In: Chemical and Pharmaceutical Bulletin, Vol. 40, No. 7, 01.01.1992, p. 1793-1798.

Research output: Contribution to journalArticle

Maeda, Minoru ; Sasaki, Shigeki ; Fukuzawa, Etsuko ; Watanabe, Kiyoko ; Kojima, K. ; Fukumura, Toshimitsu ; Tahara, Takashi ; Masuda, Kouji ; Ichiya, Yuichi. / Positron-Emitting N-[18F]Fluoroalkyl and [18F]Fluoropyrrolidinyl Analogues of Eticlopride as Potential in Vivo Radioligands for Dopamine D2 Receptors. In: Chemical and Pharmaceutical Bulletin. 1992 ; Vol. 40, No. 7. pp. 1793-1798.
@article{cbad9c9855e847ea87d45e24773b4af1,
title = "Positron-Emitting N-[18F]Fluoroalkyl and [18F]Fluoropyrrolidinyl Analogues of Eticlopride as Potential in Vivo Radioligands for Dopamine D2 Receptors",
abstract = "N-Fluoroalkyl and 4-fluoropyrrolidinyl eticlopride analogues with high affinity toward central nervous system dopamine D2 receptors in vitro were labelled with positron emitting fluorine-18 (fl/2 = 110 min), and their in vivo biodistribution was investigated in rats. 7V-[18F]Fluoro-ethyl and -propyl eticlopride derivatives showed poor in vivo selectivity in the rat brain. On the other hand, 4-[18F]fluoropyrrolidinyl eticlopride exhibited almost constant and relatively high striatal concentration. The striatal/cerebellar radioactivity ratio, which corresponds to the ratio of a brain D2 receptor-rich to poor region, gradually increased to 5.2—6.4, 90 min after the injection. The striatal accumulation was selectively inhibited by pre-injection of haloperidol, a dopamine D2 antagonist, without affecting accumulation in other tissues. Thus, the selective striatal accumulation of 4-[18F]fluoropyrrolidinyl eticlopride in striatal tissue appears to be due to the specific binding to dopamine D2 receptors.",
author = "Minoru Maeda and Shigeki Sasaki and Etsuko Fukuzawa and Kiyoko Watanabe and K. Kojima and Toshimitsu Fukumura and Takashi Tahara and Kouji Masuda and Yuichi Ichiya",
year = "1992",
month = "1",
day = "1",
doi = "10.1248/cpb.40.1793",
language = "English",
volume = "40",
pages = "1793--1798",
journal = "Chemical and Pharmaceutical Bulletin",
issn = "0009-2363",
publisher = "The Pharmaceutical Society of Japan",
number = "7",

}

TY - JOUR

T1 - Positron-Emitting N-[18F]Fluoroalkyl and [18F]Fluoropyrrolidinyl Analogues of Eticlopride as Potential in Vivo Radioligands for Dopamine D2 Receptors

AU - Maeda, Minoru

AU - Sasaki, Shigeki

AU - Fukuzawa, Etsuko

AU - Watanabe, Kiyoko

AU - Kojima, K.

AU - Fukumura, Toshimitsu

AU - Tahara, Takashi

AU - Masuda, Kouji

AU - Ichiya, Yuichi

PY - 1992/1/1

Y1 - 1992/1/1

N2 - N-Fluoroalkyl and 4-fluoropyrrolidinyl eticlopride analogues with high affinity toward central nervous system dopamine D2 receptors in vitro were labelled with positron emitting fluorine-18 (fl/2 = 110 min), and their in vivo biodistribution was investigated in rats. 7V-[18F]Fluoro-ethyl and -propyl eticlopride derivatives showed poor in vivo selectivity in the rat brain. On the other hand, 4-[18F]fluoropyrrolidinyl eticlopride exhibited almost constant and relatively high striatal concentration. The striatal/cerebellar radioactivity ratio, which corresponds to the ratio of a brain D2 receptor-rich to poor region, gradually increased to 5.2—6.4, 90 min after the injection. The striatal accumulation was selectively inhibited by pre-injection of haloperidol, a dopamine D2 antagonist, without affecting accumulation in other tissues. Thus, the selective striatal accumulation of 4-[18F]fluoropyrrolidinyl eticlopride in striatal tissue appears to be due to the specific binding to dopamine D2 receptors.

AB - N-Fluoroalkyl and 4-fluoropyrrolidinyl eticlopride analogues with high affinity toward central nervous system dopamine D2 receptors in vitro were labelled with positron emitting fluorine-18 (fl/2 = 110 min), and their in vivo biodistribution was investigated in rats. 7V-[18F]Fluoro-ethyl and -propyl eticlopride derivatives showed poor in vivo selectivity in the rat brain. On the other hand, 4-[18F]fluoropyrrolidinyl eticlopride exhibited almost constant and relatively high striatal concentration. The striatal/cerebellar radioactivity ratio, which corresponds to the ratio of a brain D2 receptor-rich to poor region, gradually increased to 5.2—6.4, 90 min after the injection. The striatal accumulation was selectively inhibited by pre-injection of haloperidol, a dopamine D2 antagonist, without affecting accumulation in other tissues. Thus, the selective striatal accumulation of 4-[18F]fluoropyrrolidinyl eticlopride in striatal tissue appears to be due to the specific binding to dopamine D2 receptors.

UR - http://www.scopus.com/inward/record.url?scp=0026630375&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026630375&partnerID=8YFLogxK

U2 - 10.1248/cpb.40.1793

DO - 10.1248/cpb.40.1793

M3 - Article

C2 - 1394695

AN - SCOPUS:0026630375

VL - 40

SP - 1793

EP - 1798

JO - Chemical and Pharmaceutical Bulletin

JF - Chemical and Pharmaceutical Bulletin

SN - 0009-2363

IS - 7

ER -